Drug Shortage Report for JANUVIA
Report ID | 153908 |
Drug Identification Number | 02388839 |
Brand name | JANUVIA |
Common or Proper name | sitagliptin tablets (as sitagliptin phosphate monohydrate) |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SITAGLIPTIN |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 Tab |
ATC code | A10BH |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-02-10 |
Actual start date | |
Estimated end date | 2022-02-17 |
Actual end date | 2022-02-09 |
Shortage status | Avoided shortage |
Updated date | 2022-02-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-02-11 | French | Compare |
v8 | 2022-02-11 | English | Compare |
v7 | 2022-02-11 | French | Compare |
v6 | 2022-01-31 | French | Compare |
v5 | 2022-01-31 | English | Compare |
v4 | 2022-01-31 | French | Compare |
v3 | 2022-01-31 | English | Compare |
v2 | 2022-01-31 | French | Compare |
v1 | 2022-01-31 | English | Compare |
Showing 1 to 9 of 9